Stripping voltammetric detection of insulin at liquid–liquid microinterfaces in the presence of bovine albumin
MetadataShow full item record
Electrochemistry at the interface between two immiscible electrolyte solutions (ITIES) provides a platform for label-free detection of biomolecules. In this study, adsorptive stripping voltammetry (AdSV) was implemented at an array of microscale ITIES for the detection of the antidiabetic hormone insulin. By exploiting the potential-controlled adsorption of insulin at the ITIES, insulin was detected at 10 nM via subsequent voltammetric desorption. This is the lowest detected concentration reported to-date for a protein by electrochemistry at the ITIES. Surface coverage calculations indicate that between 0.1 and 1 monolayer of insulin forms at the interface over the 10 – 1000 nM concentration range of the hormone. In a step toward assessment of selectivity, the optimum adsorption potentials for insulin and albumin were determined to be 0.900 V and 0.975 V, respectively. When present in an aqueous mixture with albumin, insulin was detected by tuning the adsorption potential to 0.9 V, albeit with reduced sensitivity. This provides the first example of selective detection of one protein in the presence of another by exploiting optimal adsorption potentials. The results presented here provide a route to the improvement of detection limits and achievement of selectivity for protein detection by electrochemistry at the ITIES.
Showing items related by title, author, creator and subject.
Schaefer, Rainer (2008)At present, most cancers are treated with surgery, radiotherapy and chemotherapy, used alone or in combination. Surgery and radiotherapy are the primary treatment modalities after early detection of cancers and they ...
Ishima, Y.; Maruyama, T.; Otagiri, Masaki (2015)Human serum albumin has recently emerged as a versatile carrier for therapeutic agents against diabetes, cancer and infectious diseases. Market approved products include fatty acid derivatives of human insulin or the ...
The potential of a cross-linked human serum albumin dimer in diabetic rats as an augmenting agent for antidiabetic drugsTaguchi, K.; Chuang, Victor; Yamasaki, K.; Kawai, K.; Maruyama, T.; Komatsu, T.; Otagiri, Masaki (2015)Purpose: The half-life of insulin analogs and glucagon like peptide-1 (GLP-1) receptor agonist is prolonged through binding to albumin, but this may not occur in hypoalbuminemic diabetic patients with protein leaking from ...